SecBot SecBot
SECBOTREPLAY Home › Report › ATRA

ATRA · Atara Biotherapeutics has filed an S-3 shelf registration to register…

Atara Biotherapeutics, Inc. · S-3 filed Mar 17, 2026 at 16:17 ET

At the news

NEUTRALIMPACT 4/10

S-3 filed Mar 17, 2026 at 16:17 ET

Atara Biotherapeutics has filed an S-3 shelf registration to register 400,000 shares of common stock for resale by HCR Molag Fund, L.P., a selling stockholder. These shares are issuable upon exercise of a warrant granted in connection with an amendment to a purchase agreement that extended the due date of a $9.0 million milestone payment from June 2026 to January 2028. Atara will not receive proceeds from the resale, but may receive $0.04 from the warrant exercise. The offering represents a 4.9% dilution based on current market cap.

  • S-3 filing registers 400,000 shares for resale by HCR Molag Fund, L.P.
  • Shares are issuable upon exercise of a warrant with $0.0001 exercise price.
  • Warrant was issued in connection with extending a $9.0 million milestone payment due date from June 2026 to January 2028.
  • Atara will not receive proceeds from the resale of shares by the selling stockholder.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access